Arcadia Biosciences (RKDA) Stock Analysis & Winston Score
Arcadia Biosciences is a small agricultural biotechnology company that develops crops with improved traits, like wheat with more fiber or reduced gluten. Its products target food and ingredient companies looking for healthier or more functional crop varieties. The company also sells consumer food products under its own brands, blending biotech development with direct-to-consumer sales. Arcadia earns revenue through a mix of product sales, licensing its crop trait technology, and selling branded food items. It operates primarily in the United States and is a very small company, with a market cap near zero, meaning it has limited financial resources compared to larger agricultural biotech rivals like Corteva or Bayer. The deeply negative operating margin signals the company spends far more than it earns, and its biggest risk is running out of cash before its crop traits gain meaningful commercial adoption in the food industry.
Winston Score: 11/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (4/30)
- Growth: Mixed (5/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Weak (1/15)
Key Facts
Price: $0.70
Market Cap: $1M
Sector: Basic Materials
Industry: Agricultural Inputs
Exchange: NASDAQ Capital Market
